Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
China
· Delayed Price · Currency is CNY 5.49
+0.16 (3.00%)
Apr 24, 2025, 2:45 PM CST
SHE:000908 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Net Income | -286 | -215.14 | -122.56 | -163.66 | -1,069 | -882.81 | Upgrade
|
| Depreciation & Amortization | 44 | 44 | 55.41 | 107.47 | 81.45 | 76.44 | Upgrade
|
| Other Amortization | 3 | 3 | 4.98 | 16.19 | 31.88 | 22.32 | Upgrade
|
| Loss (Gain) From Sale of Assets | -7.56 | -7.56 | -5.3 | -55.89 | 0.18 | -1.26 | Upgrade
|
| Asset Writedown & Restructuring Costs | 83.76 | 83.76 | 39.56 | 42.79 | 380.07 | 305.16 | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.1 | -4.1 | 4.09 | -238.62 | -42.18 | -66.46 | Upgrade
|
| Provision & Write-off of Bad Debts | -2.82 | -2.82 | 14.84 | 20.05 | 144.39 | 10.7 | Upgrade
|
| Other Operating Activities | 91.41 | 36.87 | 59.74 | 73.56 | 42.85 | 73.22 | Upgrade
|
| Change in Accounts Receivable | 37.39 | 37.39 | 54.92 | 254.92 | 274.02 | 449.74 | Upgrade
|
| Change in Inventory | 37.69 | 37.69 | 37.28 | 69.37 | 82.36 | -58.7 | Upgrade
|
| Change in Accounts Payable | 0.82 | 0.82 | -14.3 | -39.53 | -191.91 | 112.94 | Upgrade
|
| Operating Cash Flow | 18.74 | 35.06 | 123.27 | 123.83 | -271.68 | 36.17 | Upgrade
|
| Operating Cash Flow Growth | -62.41% | -71.55% | -0.46% | - | - | -89.69% | Upgrade
|
| Capital Expenditures | -4.48 | -10.42 | -13.52 | -38.12 | -96.04 | -113.64 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.78 | 7.51 | 118.33 | 12.01 | 1.98 | 17.43 | Upgrade
|
| Cash Acquisitions | 8.81 | - | - | 0.39 | -29.56 | -39.01 | Upgrade
|
| Divestitures | 0.65 | - | 63.6 | 253.01 | 463.74 | 174.58 | Upgrade
|
| Investment in Securities | 5 | 5.06 | 53.31 | 12.06 | 100 | -92.51 | Upgrade
|
| Other Investing Activities | -11.52 | -11.52 | - | 33.31 | 2.59 | 2.34 | Upgrade
|
| Investing Cash Flow | 2.23 | -9.37 | 221.73 | 272.66 | 442.72 | -50.81 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 4.76 | 29 | - | Upgrade
|
| Long-Term Debt Issued | - | 158 | 184.28 | 307.93 | 1,006 | 1,092 | Upgrade
|
| Total Debt Issued | 19.7 | 158 | 184.28 | 312.69 | 1,035 | 1,092 | Upgrade
|
| Long-Term Debt Repaid | - | -177.55 | -481.49 | -674.44 | -1,359 | -1,252 | Upgrade
|
| Net Debt Issued (Repaid) | 2.67 | -19.55 | -297.21 | -361.74 | -324.05 | -160.4 | Upgrade
|
| Issuance of Common Stock | 1.28 | 1.11 | 0.67 | 18.01 | - | 0.5 | Upgrade
|
| Common Dividends Paid | -22.5 | -23.61 | -39.63 | -91.49 | -89.25 | -86.56 | Upgrade
|
| Other Financing Activities | -154.27 | -150.93 | - | 47.96 | -1.42 | 152.43 | Upgrade
|
| Financing Cash Flow | -172.81 | -192.98 | -336.17 | -387.26 | -414.72 | -94.02 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.06 | -0.09 | 0.15 | -0.06 | -2.03 | 2.03 | Upgrade
|
| Net Cash Flow | -151.9 | -167.37 | 8.98 | 9.17 | -245.71 | -106.63 | Upgrade
|
| Free Cash Flow | 14.26 | 24.64 | 109.75 | 85.72 | -367.72 | -77.47 | Upgrade
|
| Free Cash Flow Growth | -57.03% | -77.55% | 28.04% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 3.59% | 3.75% | 13.05% | 10.57% | -41.89% | -5.76% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.03 | 0.13 | 0.10 | -0.42 | -0.09 | Upgrade
|
| Cash Income Tax Paid | 37.41 | 93.31 | 71.46 | 91.44 | 94.84 | 219.79 | Upgrade
|
| Levered Free Cash Flow | 83.98 | 110.2 | 187.98 | 156.56 | -70.07 | 321.44 | Upgrade
|
| Unlevered Free Cash Flow | 108.28 | 136.38 | 220.62 | 210.21 | -3.87 | 387.08 | Upgrade
|
| Change in Net Working Capital | -152.5 | -165.04 | -185.9 | -318.3 | -415.6 | -772.85 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.